Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(1):191–197. doi: 10.1111/j.1476-5381.1996.tb15385.x

Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon.

R A Panettieri Jr 1, R G Goldie 1, P J Rigby 1, A J Eszterhas 1, D W Hay 1
PMCID: PMC1909486  PMID: 8733595

Abstract

1. In this study the mitogenic effects in human cultured tracheal smooth muscle cells of endothelin-1 (ET-1), ET-3, and sarafotoxin S6c (S6c), the ETB receptor-selective agonist, were explored either alone or in combination with the potent mitogen, epidermal growth factor (EGF). 2. In confluent, growth-arrested human airway smooth, neither ET-1 (0.01 nM-1 microM) nor ET-3 (0.001 nM-1 microM) or S6c (0.01 nM-1 microM) induced cell proliferation, as assessed by [3H]-thymidine incorporation. In contrast, EGF (1.6 pM-16 nM) produced concentration-dependent stimulation of DNA synthesis (EC50 of about 0.06 nM). The maximum increase of about 60 fold above control, elicited by 16 nM EGF, was similar to that obtained with 10% foetal bovine serum (FBS). EGF (0.16-16 nM) also produced a concentration-dependent increase in cell counts, whereas ET-1 (1-100 nM) was without effect on this index of mitogenesis. 3. ET-1 (1-100 nM) potentiated EGF-induced proliferation of human tracheal smooth muscle cells. For example, ET-1 (100 nM), which alone was without significant effect, increased by 3.0 to 3.5 fold the mitogenic influence of EGF (0.16 nM). The potentiating effect of ET-1 on EGF-induced proliferation was antagonized by BQ-123 (3 microM), the ETA receptor antagonist, but was unaffected by the ETB receptor antagonist BQ-788 (10 microM). 4. Neither ET-3 (1-100 nM) nor S6c (1-100 nM) influenced the mitogenic effects of EGF (0.16-1.6 nM). 5. [125I]-ET-1 binding studies revealed that on average the ratio of ETA to ETB receptors in human cultured tracheal smooth muscle cells was 35:65 ( +/- 3; n = 4), confirming the predominance of the ETB receptor subtype in human airway smooth muscle. 6. These data indicate that ET-1 alone does not induce significant human airway smooth muscle cell proliferation. However, it potently potentiated mitogenesis induced by EGF, apparently via an ETA receptor-mediated mechanism. These findings suggest that ET-1, a mediator detected in increased amounts in patients with acute asthma, may potentiate the proliferative effects of mitogens and contribute to the airway smooth muscle hyperplasia associated with chronic severe asthma.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagnato A., Venuti A., Di Castro V., Marcante M. L. Identification of the ETA receptor subtype that mediates endothelin induced autocrine proliferation of normal human keratinocytes. Biochem Biophys Res Commun. 1995 Apr 6;209(1):80–86. doi: 10.1006/bbrc.1995.1473. [DOI] [PubMed] [Google Scholar]
  2. Bobik A., Grooms A., Millar J. A., Mitchell A., Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 1990 Mar;258(3 Pt 1):C408–C415. doi: 10.1152/ajpcell.1990.258.3.C408. [DOI] [PubMed] [Google Scholar]
  3. Bryson S. E., Drew G. M., Hall A. S., Ball S. G., Balmforth A. J. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture. Eur J Pharmacol. 1992 Jan 14;225(1):1–5. doi: 10.1016/0922-4106(92)90031-p. [DOI] [PubMed] [Google Scholar]
  4. Buchan K. W., Magnusson H., Rabe K. F., Sumner M. J., Watts I. S. Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005. Eur J Pharmacol. 1994 Aug 1;260(2-3):221–226. doi: 10.1016/0014-2999(94)90340-9. [DOI] [PubMed] [Google Scholar]
  5. DUNNILL M. S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960 Jan;13:27–33. doi: 10.1136/jcp.13.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eguchi S., Hirata Y., Ihara M., Yano M., Marumo F. A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS Lett. 1992 May 18;302(3):243–246. doi: 10.1016/0014-5793(92)80451-l. [DOI] [PubMed] [Google Scholar]
  7. Filep J. G. Endothelin peptides: biological actions and pathophysiological significance in the lung. Life Sci. 1993;52(2):119–133. doi: 10.1016/0024-3205(93)90131-l. [DOI] [PubMed] [Google Scholar]
  8. Giaid A., Polak J. M., Gaitonde V., Hamid Q. A., Moscoso G., Legon S., Uwanogho D., Roncalli M., Shinmi O., Sawamura T. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am J Respir Cell Mol Biol. 1991 Jan;4(1):50–58. doi: 10.1165/ajrcmb/4.1.50. [DOI] [PubMed] [Google Scholar]
  9. Glassberg M. K., Ergul A., Wanner A., Puett D. Endothelin-1 promotes mitogenesis in airway smooth muscle cells. Am J Respir Cell Mol Biol. 1994 Mar;10(3):316–321. doi: 10.1165/ajrcmb.10.3.7509612. [DOI] [PubMed] [Google Scholar]
  10. Goldie R. G., Grayson P. S., Knott P. G., Self G. J., Henry P. J. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction. Br J Pharmacol. 1994 Jul;112(3):749–756. doi: 10.1111/j.1476-5381.1994.tb13142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldie R. G., Henry P. J., Knott P. G., Self G. J., Luttmann M. A., Hay D. W. Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1653–1658. doi: 10.1164/ajrccm.152.5.7582310. [DOI] [PubMed] [Google Scholar]
  12. Hassoun P. M., Thappa V., Landman M. J., Fanburg B. L. Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 1992 Feb;199(2):165–170. doi: 10.3181/00379727-199-43342. [DOI] [PubMed] [Google Scholar]
  13. Hay D. W., Henry P. J., Goldie R. G. Endothelin and the respiratory system. Trends Pharmacol Sci. 1993 Jan;14(1):29–32. doi: 10.1016/0165-6147(93)90111-v. [DOI] [PubMed] [Google Scholar]
  14. Hay D. W., Hubbard W. C., Undem B. J. Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol. 1993 Sep;110(1):392–398. doi: 10.1111/j.1476-5381.1993.tb13822.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hay D. W., Luttmann M. A., Hubbard W. C., Undem B. J. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol. 1993 Nov;110(3):1175–1183. doi: 10.1111/j.1476-5381.1993.tb13938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hemsén A., Franco-Cereceda A., Matran R., Rudehill A., Lundberg J. M. Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol. 1990 Dec 4;191(3):319–328. doi: 10.1016/0014-2999(90)94164-s. [DOI] [PubMed] [Google Scholar]
  17. Henry P. J., Rigby P. J., Self G. J., Preuss J. M., Goldie R. G. Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol. 1990 Aug;100(4):786–792. doi: 10.1111/j.1476-5381.1990.tb14093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hinegardner R. T. An improved fluorometric assay for DNA. Anal Biochem. 1971 Jan;39(1):197–201. doi: 10.1016/0003-2697(71)90476-3. [DOI] [PubMed] [Google Scholar]
  19. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  20. Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., Fukuroda T., Fukami T., Ozaki S., Nagase T. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4892–4896. doi: 10.1073/pnas.91.11.4892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knott P. G., D'Aprile A. C., Henry P. J., Hay D. W., Goldie R. G. Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol. 1995 Jan;114(1):1–3. doi: 10.1111/j.1476-5381.1995.tb14895.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Komuro I., Kurihara H., Sugiyama T., Yoshizumi M., Takaku F., Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 1988 Oct 10;238(2):249–252. doi: 10.1016/0014-5793(88)80489-7. [DOI] [PubMed] [Google Scholar]
  23. Marsault R., Vigne P., Breittmayer J. P., Frelin C. Kinetics of vasoconstrictor action of endothelins. Am J Physiol. 1991 Dec;261(6 Pt 1):C987–C993. doi: 10.1152/ajpcell.1991.261.6.C986. [DOI] [PubMed] [Google Scholar]
  24. Murray R. K., Fleischmann B. K., Kotlikoff M. I. Receptor-activated Ca influx in human airway smooth muscle: use of Ca imaging and perforated patch-clamp techniques. Am J Physiol. 1993 Feb;264(2 Pt 1):C485–C490. doi: 10.1152/ajpcell.1993.264.2.C485. [DOI] [PubMed] [Google Scholar]
  25. Nakaki T., Nakayama M., Yamamoto S., Kato R. Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun. 1989 Feb 15;158(3):880–883. doi: 10.1016/0006-291x(89)92804-0. [DOI] [PubMed] [Google Scholar]
  26. Noveral J. P., Rosenberg S. M., Anbar R. A., Pawlowski N. A., Grunstein M. M. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am J Physiol. 1992 Sep;263(3 Pt 1):L317–L324. doi: 10.1152/ajplung.1992.263.3.L317. [DOI] [PubMed] [Google Scholar]
  27. Nunez D. J., Brown M. J., Davenport A. P., Neylon C. B., Schofield J. P., Wyse R. K. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest. 1990 May;85(5):1537–1541. doi: 10.1172/JCI114601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Panettieri R. A., Jr, Hall I. P., Maki C. S., Murray R. K. alpha-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 1995 Aug;13(2):205–216. doi: 10.1165/ajrcmb.13.2.7626288. [DOI] [PubMed] [Google Scholar]
  29. Panettieri R. A., Murray R. K., DePalo L. R., Yadvish P. A., Kotlikoff M. I. A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol. 1989 Feb;256(2 Pt 1):C329–C335. doi: 10.1152/ajpcell.1989.256.2.C329. [DOI] [PubMed] [Google Scholar]
  30. Panettieri R. A., Yadvish P. A., Kelly A. M., Rubinstein N. A., Kotlikoff M. I. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol. 1990 Dec;259(6 Pt 1):L365–L371. doi: 10.1152/ajplung.1990.259.6.L365. [DOI] [PubMed] [Google Scholar]
  31. Redington A. E., Springall D. R., Ghatei M. A., Lau L. C., Bloom S. R., Holgate S. T., Polak J. M., Howarth P. H. Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med. 1995 Apr;151(4):1034–1039. doi: 10.1164/ajrccm.151.4.7697227. [DOI] [PubMed] [Google Scholar]
  32. Sofia M., Mormile M., Faraone S., Alifano M., Zofra S., Romano L., Carratù L. Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration. 1993;60(2):89–95. doi: 10.1159/000196180. [DOI] [PubMed] [Google Scholar]
  33. Springall D. R., Howarth P. H., Counihan H., Djukanovic R., Holgate S. T., Polak J. M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet. 1991 Mar 23;337(8743):697–701. doi: 10.1016/0140-6736(91)90279-x. [DOI] [PubMed] [Google Scholar]
  34. Stewart A. G., Grigoriadis G., Harris T. Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle. Clin Exp Pharmacol Physiol. 1994 Apr;21(4):277–285. doi: 10.1111/j.1440-1681.1994.tb02513.x. [DOI] [PubMed] [Google Scholar]
  35. Stewart D. J., Levy R. D., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991 Mar 15;114(6):464–469. doi: 10.7326/0003-4819-114-6-464. [DOI] [PubMed] [Google Scholar]
  36. Tomlinson P. R., Wilson J. W., Stewart A. G. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol. 1994 Feb;111(2):641–647. doi: 10.1111/j.1476-5381.1994.tb14784.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Waggoner W. G., Genova S. L., Rash V. A. Kinetic analyses demonstrate that the equilibrium assumption does not apply to [125I]endothelin-1 binding data. Life Sci. 1992;51(24):1869–1876. doi: 10.1016/0024-3205(92)90038-q. [DOI] [PubMed] [Google Scholar]
  38. Weissberg P. L., Witchell C., Davenport A. P., Hesketh T. R., Metcalfe J. C. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis. 1990 Dec;85(2-3):257–262. doi: 10.1016/0021-9150(90)90118-3. [DOI] [PubMed] [Google Scholar]
  39. Williams D. L., Jr, Jones K. L., Pettibone D. J., Lis E. V., Clineschmidt B. V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 1991 Mar 15;175(2):556–561. doi: 10.1016/0006-291x(91)91601-8. [DOI] [PubMed] [Google Scholar]
  40. Zamora M. A., Dempsey E. C., Walchak S. J., Stelzner T. J. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 1993 Oct;9(4):429–433. doi: 10.1165/ajrcmb/9.4.429. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES